» Articles » PMID: 26186888

Cell-penetrating Peptides: Strategies for Anticancer Treatment

Overview
Journal Trends Mol Med
Date 2015 Jul 19
PMID 26186888
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-penetrating peptides (CPP) provide an efficient strategy for the intracellular delivery of bioactive molecules in various biomedical applications. This review focuses on recent advances in the use of CPPs to deliver anticancer therapeutics and imaging reagents to cancer cells, along with CPP contributions to novel tumor-targeting techniques. CPPs are now used extensively to deliver a variety of therapeutics, despite lacking cell specificity and having a short duration of action. Resolution of these shortcomings to enable increased cancer cell and/or tumor specificity could improve CPP-based drug delivery strategies, expand combined drug delivery possibilities, and strengthen future clinical applications of these peptides.

Citing Articles

Marine peptides in lymphoma: surgery at molecular level for therapeutic understanding.

Ahmed S, Aschner M, Alsharif K, Allahyani M, Huang G, Wan C Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39992419 DOI: 10.1007/s00210-025-03901-w.


Polymeric nanocarriers for therapeutic gene delivery.

Zhang J, Yang X, Chang Z, Zhu W, Ma Y, He H Asian J Pharm Sci. 2025; 20(1):101015.

PMID: 39931356 PMC: 11808530. DOI: 10.1016/j.ajps.2025.101015.


Detection and molecular insights into the azurin gene expression post- gamma irradiation in P. aeruginosa.

Awad E, Abdallah N, Shehata M, Farrag H Arch Microbiol. 2024; 207(1):2.

PMID: 39572437 DOI: 10.1007/s00203-024-04195-x.


Engineering of bacteria towards programmed autolysis: why, how, and when?.

Dong C, Cui S, Ren J, Gong G, Zha J, Wu X Microb Cell Fact. 2024; 23(1):293.

PMID: 39465360 PMC: 11514776. DOI: 10.1186/s12934-024-02566-z.


A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant.

Euliano E, Pogostin B, Agrawal A, Yu M, Baryakova T, Graf T Adv Healthc Mater. 2024; 14(3):e2402958.

PMID: 39460390 PMC: 11774675. DOI: 10.1002/adhm.202402958.